ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:12 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 37
Drug details and screening numbers
Drug Name: Crizotinib
Drug ID: 37
Synonyms: PF-02341066
Brand name: Xalkori
Target: MET, ALK
Number of cell lines screened: 408
Screening concentration range(s): 0.0078125 to 2 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a412 |
BCR-ABL_mut |
37 |
1 |
1 |
Crizotinib |
MET, ALK |
5 |
402 |
0.693 |
2.41 |
0.187 |
-2.22 |
2 * |
2 * |
2.3 ** |
4.96e-04 |
4.97e-11 |
6.04e-01 |
20 |
All-tests volcano plot